Orrick Advises Vostok as Part of $231 Million Series D Investment in Creditas
Jonathan has always been active in the tech and venture space. After college, he joined TetraLogic Pharmaceuticals, a venture-backed startup biotech company based in the Philadelphia area. As one of the first employees with TetraLogic, Jonathan was a cancer researcher focused on the discovery and development of small molecule targeted chemotherapeutics.
Nowadays, Jonathan no longer sports a lab coat or plays with pipettes. Instead of solving biomolecular puzzles, he now helps startups and other clients solve their puzzles. Jonathan is industry-agnostic when it comes to representing companies and investors; he has represented clients involved in a variety of sectors, including financial services, digital media, AI, robotics, biotechnology, social media, ed-tech, SaaS, fashion, cleantech, enterprise software, legal tech, e-commerce, ad-tech and more.
Even after representing hundreds of startup clients, Jonathan hasn't forgotten his days at TetraLogic, and this helps him relate to (and connect with) founders on a personal level. Because of their shared experiences, Jonathan sees himself not only as an outside general counsel to founders and companies across the spectrum, but also as their advisor and friend who can occasionally add a dose of business practicality to solving their legal issues.